首页 | 本学科首页   官方微博 | 高级检索  
检索        

脑梗死患者组织因子途径抑制物基因-287T/C多态性
引用本文:黄灿,侯丽虹,李参,卫晓华.脑梗死患者组织因子途径抑制物基因-287T/C多态性[J].中国药物与临床,2012,12(7):854-856.
作者姓名:黄灿  侯丽虹  李参  卫晓华
作者单位:1. 山西医科大学研究生学院,太原,030001
2. 山西医科大学第二医院血液科
基金项目:山西省自然科学基金(2010011050-5)
摘    要:目的分析脑梗死患者组织因子途径抑制物(TFPI)基因-287T/C多态性,探讨TFPI基因多态性与脑梗死形成的关系。方法应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)的方法检测114例脑梗死患者、116名健康人作为对照的TFPI-287T/C基因型频率和等位基因频率。结果脑梗死组和对照组TFPI基因-287T/C多态性基因型频数分布符合Hardy-Weinberg平衡。脑梗死组TFPI-287T/C具有杂合突变型(TC)基因型个体的频数(43.9%)高于健康对照组(31.0%),差异有统计学意义(χ2=4.040,P<0.05);C等位基因频率分布也高于对照组(χ2=5.831,P<0.05);正常纯合子(TT)基因型个体的频数(45.6%)低于健康对照组(62.1%),差异有统计学意义(χ2=6.265,P<0.05)。结论 TFPI基因-287T/C多态性与我国人群脑梗死易感性有关,杂合突变基因型可能是脑梗死的重要危险因素。

关 键 词:脑梗塞  多态性  限制性片段长度  组织因子途径抑制物

The polymorphism of tissue factor pathway inhibitor-287T/C in patients with cerebral infarction
HUANG Can , HOU Li-hong , LI Can , WEI Xiao-hua.The polymorphism of tissue factor pathway inhibitor-287T/C in patients with cerebral infarction[J].Chinese Remedies & Clinics,2012,12(7):854-856.
Authors:HUANG Can  HOU Li-hong  LI Can  WEI Xiao-hua
Institution:.The Graduate School of Shanxi Medical University,Taiyuan 030001,China
Abstract:Objective To investigate the polymorphism of tissue factor pathway inhibitor(TFPI)-287T/C in patients with cerebral infarction(CI),and to explore the correlation between TFPI gene polymorphism and CI.Methods One hundred and fourteen CI patients were detected for their genotype frequency and allele frequency of TFPI-287T/C using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP),while 116 normal people were assigned as controls.Results The genotype frequency distributions of the TFPI gene-287T/C polymorphism were found to accord with the Hardy-Weinberg balance in both CI and control groups.The heterozygosis mutant type TC frequencies were higher in CI group(43.9%) as compared with that in control group(31.0%)(χ2=4.040,P〈0.05).Furthermore,the C allele gene frequency in CI group is also higher than that in control group(χ2=5.831,P〈0.05).Nevertheless,the TT frequency in CI group(45.6%) was significantly lower than that in control group(62.1%)(χ2=6.265,P〈0.05).Conclusion The TFPI-287T/C polymorphism was correlated with the susceptibility of CI.Heterozygous mutation genotype might be the important risk factor to cause CI.
Keywords:Brain infarction  Polymorphism  restriction frament length  Tissue factor pathway inhibitor
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号